Antibiotic penetration of phagocytic cells may be a critical factor in the fate of intracellular bacteria. It is reported that phagocytized bacteria are protected from the effect of antibiotics (5, 10, 19, 21) ; however, enhancement of the bactericidal capacity of polymorphonuclear leukocytes (PMN) may be secondary to the effect of antibiotic-exposed bacteria before phagocytosis. Even at subinhibitory concentrations of antibiotics, bacterial morphology (2, 9, 18) , adherence properties (15) , opsonic requirements (2) , and kinetics of phagocytosis and killing by PMN are altered (1, 2, 6, 9, 11, 17, 18) .
In this investigation, we evaluated the effects of subinhibitory concentrations of penicillin, cephalothin, and clindamycin on the intracellular multiplication of Staphylococcus aureus in PMN obtained from healthy donors and from patients with chronic granulomatous disease (CGD) and in human alveolar macrophages (AMW). Despite different capacities to penetrate phagocytic cells, these antibiotics acted synergistically with PMN to reduce the intracellular survival of S. aureus.
MATERIALS AND METHODS Preparation of bacteria. S. aureus Cowan I stock culture was inoculated in 10 ml of Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) and placed in a 37°C shaker incubator for 18 h. The bacteria were harvested, washed three times with phosphate-buffered saline (pH 7.4), and then adjusted to 5 x 108 colony-forming units (CFU) per ml in RPMI 1640 medium (GIBCO Laboratories, Grand Island, N.Y.).
Antimicrobial agents. Clindamycin, cephalothin, and penicillin G standard powders were concentrated in 10-mg/ml stock solutions by the method of Washington and Barry (23) . Clindamycin was supplied by The Upjohn Co., Kalamazoo, Mich., cephalothin was supplied by Eli Lilly & Co., Indianapolis, Ind., and penicillin G (PEN-NA) was supplied by Sigma Chemical Co., St. Louis, Mo. Minimal inhibitory concentrations (MICs) were determined by a standard broth dilution technique (14) . When RPMI 1640 medium was used in the MIC determinations, the endpoints were either the same or varied by less than one dilution. The MICs for S. aureus used in this report were 0.5 ,ug/ml for clindamycin and cephalothin and 0.1 ,ug/ml for penicillin G.
Preparation of PMN. Heparinized venous blood (10 U of heparin per ml of blood) was obtained from healthy adults and from uninfected patients with CGD. Whole blood was settled by gravity with 6% dextran in normal saline (3 ml of dextran per 10 ml of blood), and the PMN-rich supernatant was layered on Lymphocyte Separation Medium (Litton Bionetics, Kensington, Md.). After centrifugation for 30 min at 300 x g, the pellet was removed, the erythrocytes were lysed with 0.87% NH4Cl, and the remaining PMN were washed three times in Hanks balanced salt solution containing 0.1% gelatin. Final volumes were adjusted to This number of CFU was used as the zero time for the initiation of intracellular growth. The postphagocytic mixture was then divided into 0.2-ml samples in a 24-well tissue culture plate (Costar, Cambridge, Mass.), and 0.2 ml of RPMI 1640 medium was added to each well. Antibiotics were added to the tissue culture medium in concentrations of 1/10 or 1/40 the MIC. After 16 h, the cells were lysed with sterile water, serially diluted, and the number of CFU was determined. Most assays were done three times each with triplicate samples. The number of CFU present at the zero postphagocytic time was compared with the number of CFU after the 16-h time to quantify growth. Cells were also examined microscopically at 10 and 16 h and compared with cells at the zero time for morphological evaluation of intracellular bacterial growth.
ViabilIty and chemiluminescence assays. Viability of phagocytes at various times over the 16-h incubation period was determined by trypan blue exclusion. In addition, cells were evaluated for their ability to elicit a chemiluminescence response to opsonized zymosan at the various times, using a luminol-enhanced chemiluminescence assay (12) .
RESULTS
Two hours after adding 2. however, this increase was significantly less than that observed with the control. Figure 2A through C shows representative ility was greater than 95% as changes observed microscopically in PMN after exclusion.
incubation with S. aureus for the zero, 10-, and nd postphagocyc determnna-16-h times in the control wells. More intracelluth. Phagocytic mixtures con-lar S. aureus cells were visible at 10 h than at the ation of 10%o pooled human zero time, and after 16 h, both intracellular and f S. aureus per ml, and PMN extracellular bacteria were observed. Figure 2D -phagocyte ratio of 10:1 were shows the absence of intracellular growth of incubator for 2 h to obtain bacteria when incubated in the presence of 1/10 nmediately before incubation the MIC of clindamycin. by addition of 0.1 ml of the When S. aureus were incubated with PMN sterile water. Serial dilutions from patients with CGD, there was a higher crotiter plates (Flow Labora-number of CFU at zero time (Fig. 1B) as com4d.) to determine the number pared with the number observed with normal fter the 2-h incubation, lyso-PMN. However, intracellular survival of S. auon, 2 ,ug/ml) was added to the reus in the presence of sub-MICs of penicillin, ich was then tumbled on a cephalothin, and clindamycin was similar in c Co., Pittsburgh, Pa.) for 30 PMN from patients with CGD and normal PMN.
Acas then washed three times The bactericidal capacity of AMO was similar medium, and a 0.1-mi sample to that of PMN from patients with CGD, with 4 ie the number of viable intra-x 105 intracellular S. aureus per ml present at love serial dilution technique. the zero time (Fig. 1C) It has recently been demonstrated that the concentration of clindamycin within normal PMN is up to 40 times higher than that in the extracellular milieu (8, 16) . Our findings may be explained by this property of clindamycin; however, sub-MICs of penicillin and cephalothin also prevented intracellular survival of S. aureus. Most studies of antibiotic penetration into phagocytic cells have not been carried out with cells which had already participated in phagocytosis. It seems possible that penicillin and cephalothin may penetrate PMN because the PMN had phagocytized S. aureus before incubation with antibiotics. Veal et al. (22) showed that penicillin penetrates PMN containing gonococci. Root et al. (18) have shown that S. aureus killing was enhanced by pretreatment with subMICs of penicillin before phagocytosis. Since low concentrations of these antibiotics may enter cells (16) , they may alter the bacterial cell wall, rendering S. aureus more susceptible to PMN bactericidal activity.
Other investigators ( that clindamycin is actively concentrated by rabbit AM¢; however, they did not find an antimicrobial effect on intracellular staphylococci (7) . In the present study, we used human AMO from healthy donors and were similarly unable to find an inhibitory effect of sub-MICs of clindamycin on intracellular growth of S. aureus. Cephalothin was also unable to significantly limit the growth of S. aureus that had been ingested by human AMO; however, in one test, penicillin did inhibit growth somewhat. These findings suggest that an oxygen-independent antimicrobial system of PMN is responsible for the killing of staphylococci in the presence of sub-MICs of antibiotics in PMN and that these factors are either not operative or not optimally effective in human AMF.
Antibiotics may be clinically effective even if infecting bacteria are insensitive by standard in vitro sensitivity testing. The results of this study suggest that this laboratory-clinical paradox may be explained by the antibacterial activity of antibiotics at concentrations well below the in vitro inhibitory concentrations in the presence of PMN. 
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